Natera, Inc. (NTRA)
NASDAQ: NTRA · IEX Real-Time Price · USD
+2.00 (1.86%)
May 24, 2024, 4:00 PM EDT - Market closed

Natera Revenue

Natera had revenue of $1.21B in the twelve months ending March 31, 2024, with 39.26% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $367.74M with 52.11% year-over-year growth. In the year 2023, Natera had annual revenue of $1.08B with 31.99% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
13.45B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20231.08B262.35M31.99%
Dec 31, 2022820.22M194.74M31.13%
Dec 31, 2021625.49M234.48M59.97%
Dec 31, 2020391.01M88.68M29.33%
Dec 31, 2019302.33M44.67M17.34%
Dec 31, 2018257.65M48.03M22.91%
Dec 31, 2017209.63M-2.89M-1.36%
Dec 31, 2016212.51M22.16M11.64%
Dec 31, 2015190.36M31.07M19.50%
Dec 31, 2014159.29M104.12M188.72%
Dec 31, 201355.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Walgreens Boots Alliance 144.60B
Tenet Healthcare 20.91B
Quest Diagnostics 9.29B
Incyte 3.77B
Revvity 2.73B
BioMarin Pharmaceutical 2.47B
Neurocrine Biosciences 1.98B
Insulet 1.78B
Revenue Rankings